Prevalence of Irritable Bowel Syndrome and Chronic Fatigue 10 Years After Giardia Infection - PubMed (original) (raw)
. 2018 Jul;16(7):1064-1072.e4.
doi: 10.1016/j.cgh.2018.01.022. Epub 2018 Mar 6.
Affiliations
- PMID: 29378314
- DOI: 10.1016/j.cgh.2018.01.022
Free article
Prevalence of Irritable Bowel Syndrome and Chronic Fatigue 10 Years After Giardia Infection
Sverre Litleskare et al. Clin Gastroenterol Hepatol. 2018 Jul.
Free article
Abstract
Background & aims: Irritable bowel syndrome (IBS) is a complication that can follow gastrointestinal infection, but it is not clear if patients also develop chronic fatigue. We investigated the prevalence and odds ratio of IBS and chronic fatigue 10 years after an outbreak of Giardia lamblia, compared with a control cohort, and changes in prevalence over time.
Methods: We performed a prospective follow-up study of 1252 laboratory-confirmed cases of giardiasis (exposed), which developed in Bergen, Norway in 2004. Statistics Norway provided us with information from 2504 unexposed individuals from Bergen, matched by age and sex (controls). Questionnaires were mailed to participants 3, 6, and 10 years after the outbreak. Results from the 3- and 6-year follow-up analyses have been published previously. We report the 10-year data and changes in prevalence among time points, determined by logistic regression using generalized estimating equations.
Results: The prevalence of IBS 10 years after the outbreak was 43% (n = 248) among 576 exposed individuals and 14% (n = 94) among 685 controls (adjusted odds ratio for development of IBS in exposed individuals, 4.74; 95% CI, 3.61-6.23). At this time point, the prevalence of chronic fatigue was 26% (n = 153) among 587 exposed individuals and 11% (n = 73) among 692 controls (adjusted odds ratio, 3.01; 95% CI, 2.22-4.08). The prevalence of IBS among exposed persons did not change significantly from 6 years after infection (40%) to 10 years after infection (43%; adjusted odds ratio for the change 1.03; 95% CI, 0.87-1.22). However, the prevalence of chronic fatigue decreased from 31% at 6 years after infection to 26% at 10 years after infection (adjusted odds ratio for the change 0.74; 95% CI, 0.61-0.90).
Conclusion: The prevalence of IBS did not change significantly from 6 years after an outbreak of Giardia lamblia infection in Norway to 10 years after. However, the prevalence of chronic fatigue decreased significantly from 6 to 10 years afterward. IBS and chronic fatigue were still associated with giardiasis 10 years after the outbreak.
Keywords: Bacteria; Epidemiology; Long-Term Outcome; Microbiota.
Copyright © 2018 AGA Institute. Published by Elsevier Inc. All rights reserved.
Comment in
- Irritable Bowel Syndrome Symptoms Following Giardiasis.
Miner PB Jr. Miner PB Jr. Clin Gastroenterol Hepatol. 2019 Jun;17(7):1416. doi: 10.1016/j.cgh.2018.08.058. Epub 2018 Aug 25. Clin Gastroenterol Hepatol. 2019. PMID: 30153520 No abstract available.
Similar articles
- Irritable bowel syndrome and chronic fatigue 3 years after acute giardiasis: historic cohort study.
Wensaas KA, Langeland N, Hanevik K, Mørch K, Eide GE, Rortveit G. Wensaas KA, et al. Gut. 2012 Feb;61(2):214-9. doi: 10.1136/gutjnl-2011-300220. Epub 2011 Sep 12. Gut. 2012. PMID: 21911849 - The impact of atopic disease on the risk of post-infectious fatigue and irritable bowel syndrome 3 years after Giardia infection. A historic cohort study.
Hunskar GS, Langeland N, Wensaas KA, Hanevik K, Eide GE, Mørch K, Rortveit G. Hunskar GS, et al. Scand J Gastroenterol. 2012 Sep;47(8-9):956-61. doi: 10.3109/00365521.2012.696681. Epub 2012 Jul 2. Scand J Gastroenterol. 2012. PMID: 22746290 - Irritable bowel syndrome and chronic fatigue 6 years after giardia infection: a controlled prospective cohort study.
Hanevik K, Wensaas KA, Rortveit G, Eide GE, Mørch K, Langeland N. Hanevik K, et al. Clin Infect Dis. 2014 Nov 15;59(10):1394-400. doi: 10.1093/cid/ciu629. Epub 2014 Aug 12. Clin Infect Dis. 2014. PMID: 25115874 Free PMC article. - The neglected role of Blastocystis sp. and Giardia lamblia in development of irritable bowel syndrome: A systematic review and meta-analysis.
Abedi SH, Fazlzadeh A, Mollalo A, Sartip B, Mahjour S, Bahadory S, Taghipour A, Rostami A. Abedi SH, et al. Microb Pathog. 2022 Jan;162:105215. doi: 10.1016/j.micpath.2021.105215. Epub 2021 Sep 27. Microb Pathog. 2022. PMID: 34592369 - Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis.
Chen B, Kim JJ, Zhang Y, Du L, Dai N. Chen B, et al. J Gastroenterol. 2018 Jul;53(7):807-818. doi: 10.1007/s00535-018-1476-9. Epub 2018 May 14. J Gastroenterol. 2018. PMID: 29761234
Cited by
- Health sequelae of human cryptosporidiosis in industrialised countries: a systematic review.
Carter BL, Chalmers RM, Davies AP. Carter BL, et al. Parasit Vectors. 2020 Sep 4;13(1):443. doi: 10.1186/s13071-020-04308-7. Parasit Vectors. 2020. PMID: 32887663 Free PMC article. - Differential gene expression (DGE) analysis in persons with a history of giardiasis.
Saeedi P, Eslami G, Tohidfar M, Jafari-Nodushan A, Vakili M. Saeedi P, et al. AMB Express. 2024 Jan 3;14(1):1. doi: 10.1186/s13568-023-01657-1. AMB Express. 2024. PMID: 38170269 Free PMC article. - Coenzyme Q10 + alpha lipoic acid for chronic COVID syndrome.
Barletta MA, Marino G, Spagnolo B, Bianchi FP, Falappone PCF, Spagnolo L, Gatti P. Barletta MA, et al. Clin Exp Med. 2023 Jul;23(3):667-678. doi: 10.1007/s10238-022-00871-8. Epub 2022 Aug 22. Clin Exp Med. 2023. PMID: 35994177 Free PMC article. Review. - The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.
Moghimi N, Di Napoli M, Biller J, Siegler JE, Shekhar R, McCullough LD, Harkins MS, Hong E, Alaouieh DA, Mansueto G, Divani AA. Moghimi N, et al. Curr Neurol Neurosci Rep. 2021 Jun 28;21(9):44. doi: 10.1007/s11910-021-01130-1. Curr Neurol Neurosci Rep. 2021. PMID: 34181102 Free PMC article. Review. - Outbreak of Cryptosporidium hominis in northern Sweden: persisting symptoms in a 5-year follow-up.
Sjöström M, Arvidsson M, Söderström L, Lilja M, Lindh J, Widerström M. Sjöström M, et al. Parasitol Res. 2022 Jul;121(7):2043-2049. doi: 10.1007/s00436-022-07524-5. Epub 2022 Apr 22. Parasitol Res. 2022. PMID: 35451705 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical